Is a
Other attributes
Investors
Latest Funding Round Date
August 28, 2020
Patents Assigned (Count)
1
Total Funding Amount (USD)
22,500,000
Movano develops a wearable, non-invasive continuous glucose monitor (CGM) that is painless, simple, and smart. The company employs cutting-edge, multi-antenna Radio Frequency (RF) technology, empowering individuals to confidently manage their glucose levels in ways that best fit their lifestyle.
Timeline
No Timeline data yet.